Search Details

Word: bille (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...CANDIDATE] BILL BRADLEY...

Author: /time Magazine | Title: Presidency...or Pulitzer? | 11/22/1999 | See Source »

Microsoft chairman Bill Gates talked to TIME managing editor Walter Isaacson last week about his reaction to a federal court's findings of fact in the government's antitrust case against his company...

Author: /time Magazine | Title: Bill Gates: They're Trying to Change the Rules | 11/22/1999 | See Source »

...Wall Street plutocracy that seemed to live inside the Pop artist's reverie of an endless spree of sensations and spectacles acquired, used up and instantly replaced. This is not to say that work harkening to the spiritual, to quieter introspection, wasn't being done. Such abstract artists as Bill Jensen, Sean Scully and Christopher Wilmarth were making some of their best work, but their belief in the poetic possibilities of doubt were no longer the currency...

Author: /time Magazine | Title: Art: Creative Chaos | 11/22/1999 | See Source »

...best friends, both former legislators. "They were in to see me once or twice" about the lawsuit, Miller says, and he's also heard from two former state A.G.s making Microsoft's arguments. A similar strategy seems to be at work in California, where, according to attorney general Bill Lockyer, the company hired a former state senator who is "a very close friend of mine." In West Virginia, Microsoft has taken a tougher tack. According to attorney general Darrell McGraw, it has hired a lobbying firm run by someone McGraw defeated in an earlier race; the lobbyists have attacked...

Author: /time Magazine | Title: The Microsoft Antitrust Case | 11/22/1999 | See Source »

...drugs are rare. The last one, granted in 1996, was for the popular arthritis drug Daypro. So Schering-Plough has tried to work the system every way it can. First it wanted Congress to approve a straight extension of its patent. When that didn't fly, it tried a bill that would have shifted any patent-extension decision away from Congress to a new review board at the Patent and Trademark Office, and defined criteria for such extensions in ways that tended to favor the drug companies. But that bill, quietly introduced by New Jersey Senator Frank Lautenberg, failed. This...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

Previous | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | Next